The renin-angiotensin system (RAS) is implicated in the response to physiological and psychosocial stressors, but its role in stress-related psychiatric disorders is poorly understood. We examined if variation in AGTR1, the gene coding for the type 1 angiotensin II receptor (AT 1 R), is associated with a diagnosis of depression and differences in white matter hyperintensities and frontotemporal brain volumes. Participants comprised 257 depressed and 116 nondepressed elderly Caucasian subjects who completed clinical assessments and provided blood samples for genotyping. We used a haplotype-tagging single nucleotide polymorphism (htSNP) analysis to test for variation in AGTR1. For measurement of hyperintense lesions, 1.5 Tesla magnetic resonance imaging (MRI) data were available on 33 subjects. For measurements of the hippocampus and dorsolateral prefrontal cortex (dlPFC), 3 Tesla MRI data were available on 70 subjects. Two htSNPs exhibited statistically significant frequency differences between diagnostic cohorts: rs10935724 and rs12721331. Although hyperintense lesion volume did not significantly differ by any htSNP, dlPFC and hippocampus volume differed significantly for several htSNPs. Intriguingly, for those htSNPs differing significantly for both dlPFC and hippocampus volume, the variant associated with smaller dlPFC volume was associated with larger hippocampal volume. This supports the idea that genetic variation in AGTR1 is associated with depression and differences in frontotemporal morphology.
Introduction
There has been significant progress in elucidating the neural circuitry contributing to the pathogenesis of major depressive disorder (MDD). Through a variety of approaches, this work has been partially integrated with molecular hypotheses of MDD, examining how variation in monoamine systems, the hypothalamic-pituitary-adrenal (HPA) axis, and neurotrophic function may influence the structure and function of frontal, cingulate, and temporal regions. However, we need to look beyond these systems to identify other influences on neural circuitry which will inform us of the pathophysiology of MDD and guide potential new therapeutic approaches (Krishnan and Nestler, 2010) . The renin-angiotensin system (RAS) is such a candidate system.
Although the systemic RAS is best known for regulation of fluid homeostasis and blood pressure, there is also a brain-specific RAS that plays a crucial role in the response to physiological and psychosocial stressors (Saavedra et al., 2011) . Increased RAS activity, mediated by angiotensin II, directly influences many molecular systems implicated in MDD, including 1) stimulation of the HPA axis by stimulating the production and release of corticotrophin releasing factor (CRF) (Aguilera et al., 1995) ; 2) inhibition of neurogenesis and neuroplasticity (Castren, 2005; De Bundel et al., 2008) ; 3) increase in expression of proinflammatory cytokines (Miller et al., 2009; Lanz et al., 2010) ; and 4) regulation of monoamine neurotransmitters, particularly norepinephrine (Gelband et al., 1997) . Thus the RAS is activated by a variety of systems and in turn it influences other systems implicated in the pathogenesis of MDD. Moreover, animal studies have demonstrated that RAS-blocking drugs reduce depressive behavior across several paradigms (Giardina and Ebert, 1989; Martin et al., 1990; Gard et al., 1999; Gard, 2002; Nayak and Patil, 2008) , with effects comparable to those observed with tricyclic antidepressants (Gard et al., 1999; Nayak and Patil, 2008) .
Despite this theoretical link between the RAS and MDD, this potential relationship has not been widely examined. There have been scattered studies examining relationships between MDD and genetic variation in several RAS elements, including genes coding for angiotensin converting enzyme (ACE; chromosome 17), angiotensinogen (AGT; chromosome 1), and angiotensin-II AT 1 receptors (AT 1 R) (AGTR1; chromosome 3). Examination of specific, isolated polymorphisms in these genes has not resulted in replicable associations with MDD (Arinami et al., 1996; Baghai et al., 2006; Lopez-Leon et al., 2006; Saab et al., 2007; Lopez-Leon et al., 2008; Sparks et al., 2009) 
